Both in Pharmaceuticals
Impact BioMedical vs Biote
Over the past year IBO returned −40.2% and BTMD returned −60.4%; their daily moves had a correlation of 0.03.
IBO −40.2% BTMD −60.4%Growth of $1, one year, split-adjusted
| Metric | IBO | BTMD |
|---|---|---|
| Price | $4.02 | $1.12 |
| Market cap | $34.3M | $32.1M |
| Today | +0.25% | −0.89% |
| 1 month | −16.9% | 0.0% |
| 6 months | −50.5% | −49.3% |
| Year to date | −36.9% | −56.9% |
| 1 year | −40.5% | −61.0% |
| Revenue growth (YoY) | −57.1% | −9.5% |
| Gross margin | −533.3% | 65.4% |
| Net margin | −23300.0% | −14.8% |
| P/E (TTM) | 43.5× | 5.5× |
| Price / sales | 981.3× | 0.2× |
| Net cash | $10.0K | -$110.3M |
| Dividend yield | — | — |
| Volatility (60d) | 736.6% | 66.7% |
| Short % of float | 2.6% | 5.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).